Review of Cutaneous Manifestations in Myhre Syndrome With Histopathological Analyses and Genotype–Phenotype Correlation
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2025
DOI: 10.1002/ajmgc.70005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2025. Verfasst von Setu Mittal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Smad4 Protein, Cryptorchidism, Intellectual Disability, Hand Deformities, Congenital. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Mayo Clinic Comprehensive Cancer Center, NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Myhre syndrome is a rare multisystem disorder characterized by distinctive facial features, hearing loss, and progressive fibrosis affecting the skin, joints, lungs, and cardiovascular system. It is caused by heterozygous pathogenic variants in the SMAD4 gene. In this review, we detail the cutaneous manifestations observed in two previously reported patients with genetically confirmed Myhre syndrome. While skin biopsies demonstrated pan‐dermal thickening of collagen bundles, the immunohistochemical staining patterns were distinct from those seen in other inflammatory sclerosing disorders. Additionally, we conducted a comprehensive literature review of the cutaneous features associated with Myhre syndrome, identifying 175 patients with confirmed SMAD4 pathogenic variants. The most reported cutaneous finding was thickened or stiff skin (76%), followed by keratosis pilaris (22%) and impaired wound healing or abnormal scarring (18%). Genotype–phenotype analysis suggested a diagnostic delay in patients with the codon 496 variant, who were more frequently diagnosed in adulthood. This variant may also be associated with a milder cutaneous phenotype, highlighting the clinical heterogeneity of Myhre syndrome. These findings underscore the importance of recognizing cutaneous features as potential early diagnostic clues in patients with suspected Myhre syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Otorhinolaryngology, Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Setu Mittal, Emma F Johnson, Lisa A Schimmenti
Förderung
- Mayo Clinic Comprehensive Cancer Center
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Mittal, S., Johnson, E. F., Schimmenti, L. A., & Mohandesi, N. A. (2025). Review of Cutaneous Manifestations in Myhre Syndrome With Histopathological Analyses and Genotype–Phenotype Correlation. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. https://doi.org/10.1002/ajmgc.70005
Vancouver
Mittal S, Johnson EF, Schimmenti LA, Mohandesi NA. Review of Cutaneous Manifestations in Myhre Syndrome With Histopathological Analyses and Genotype–Phenotype Correlation. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2025. doi:10.1002/ajmgc.70005
BibTeX
@article{Mittal2025,
author = {Mittal, Setu and Johnson, Emma F and Schimmenti, Lisa A and Mohandesi, Nessa Aghazadeh},
title = {Review of Cutaneous Manifestations in Myhre Syndrome With Histopathological Analyses and Genotype–Phenotype Correlation},
journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
year = {2025},
doi = {10.1002/ajmgc.70005}
}
EUVIMED